Guided Therapeutics (GTHP) Current Assets (2010 - 2025)

Guided Therapeutics (GTHP) has 16 years of Current Assets data on file, last reported at $605000.0 in Q4 2025.

• For the quarter ending Q4 2025, Current Assets fell 49.46% year-over-year to $605000.0; the trailing twelve-month figure through Dec 2025 stood at $605000.0 (down 49.46% YoY), and the FY2025 full-year result was $605000.0, down 49.46% from the prior year.
• Current Assets fell to $605000.0 in Q4 2025, from $799000.0 in the prior quarter.
• In the past five years, Current Assets ranged from a high of $3.5 million in Q3 2022 to a low of $605000.0 in Q4 2025.
• A 5-year average of $1.5 million and a median of $1.4 million in 2021 frame the typical range for Current Assets.
• Across the five-year window, Current Assets soared 705.04% in 2021 and slumped 54.8% in 2023, its largest moves.
• Tracing GTHP's Current Assets over 5 years: stood at $1.6 million in 2021, then soared by 83.51% to $3.0 million in 2022, then slumped by 53.63% to $1.4 million in 2023, then slipped by 14.07% to $1.2 million in 2024, then plunged by 49.46% to $605000.0 in 2025.
• Business Quant data shows GTHP's Current Assets at $605000.0 in Q4 2025, $799000.0 in Q3 2025, and $811000.0 in Q2 2025.